Skip to main content
. 2019 Apr-Jun;8(2):112–115. doi: 10.4103/sajc.sajc_89_18

Table 2.

Overall tumor response in patients treated with nimotuzumab and standard treatment

Overall tumor response n (%)
CR 5 (33.3)
PR 10 (66.7)
SD 0
PD 0
ORR 15 (100)

CR=Complete response, PR=Partial response, SD=Stable disease, PD=Progressive disease, ORR=Objective response rate